PXYN / Praxsyn Corporation - SEC Filings, Annual Report, Proxy Statement

Praxsyn Corporation
US ˙ OTCPK

Basic Stats
CIK 1346973
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Praxsyn Corporation
SEC Filings (Chronological Order)
This page provides a complete, chronological list of SEC Filings, excluding ownership filings which we provide elsewhere.
March 5, 2019 15-15D

PXYN / Praxsyn Corporation

OMB APPROVAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB Number: 3235-0167 Expires: May 31, 2021 Estimated average burden hours per response. 2.50 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT O

September 28, 2018 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 26, 2018 PRAXSYN CORPORATION (Exact name of registrant as specified in its charter) Nevada 333-130446 20-3191557 (State or other jurisdiction of incorporation) (Commission F

September 20, 2018 8-K

Unregistered Sales of Equity Securities, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 14, 2018 PRAXSYN CORPORATION (Exact name of registrant as specified in its charter) Nevada 333-130446 20-3191557 (State or other jurisdiction of incorporation) (Commission F

September 10, 2018 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): September 1, 2018 PRAXSYN CORPORATION (Exact name of Registrant as specified in its charter) Nevada 333-130446 20-3191557 (State or other jurisdiction of incorporation) (Commissio

July 10, 2018 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): July 2, 2018 PRAXSYN CORPORATION (Exact name of Registrant as specified in its charter) Nevada 333-130446 20-3191557 (State or other jurisdiction of incorporation) (Commission Fil

December 21, 2017 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): December 15, 2017 PRAXSYN CORPORATION (Exact name of Registrant as specified in its charter) Nevada 333-130446 20-3191557 (State or other jurisdiction of incorporation) (Commissio

November 20, 2017 NT 10-Q

PXYN / Praxsyn Corporation 0-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR For Period Ended: September 30, 2017 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] Transition Report on For

August 25, 2017 NT 10-Q

Praxsyn 0-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One) [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR For Period Ended: June 30, 2017 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] Transition Report on Form N-SA

August 16, 2017 NT 10-Q

Praxsyn 0-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One) [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR For Period Ended: March 31, 2017 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] Transition Report on Form N-S

June 28, 2017 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): April 20, 2016 PRAXSYN CORPORATION (Exact name of Registrant as specified in its charter) Nevada 333-130446 20-3191557 (State or other jurisdiction (Commission (IRS Employer of in

April 27, 2017 8-K

Entry into a Material Definitive Agreement, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): December 30, 2016 PRAXSYN CORPORATION (Exact name of Registrant as specified in its charter) Nevada 333-130446 20-3191557 (State or other jurisdiction of incorporation) (Commissio

March 31, 2017 NT 10-K

Praxsyn 0-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One) [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form N-SAR For Period Ended: December 31, 2016 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] Transition Report on Form

November 15, 2016 NT 10-Q

Praxsyn 0-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One) [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR For Period Ended: September 30, 2016 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] Transition Report on Form

August 16, 2016 NT 10-Q

Praxsyn 0-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One) [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR For Period Ended: June 30, 2016 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] Transition Report on Form N-SA

August 16, 2016 NT 10-Q

Praxsyn 0-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One) [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR For Period Ended: June 30, 2016 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] Transition Report on Form N-SA

June 21, 2016 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): June 8, 2016 PRAXSYN CORPORATION (Exact name of Registrant as specified in its charter) Nevada 333-130446 20-3191557 (State or other jurisdiction of incorporation) (Commission Fil

May 17, 2016 NT 10-Q

Praxsyn 0-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One) [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR For Period Ended: March 31, 2016 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] Transition Report on Form N-S

April 6, 2016 8-K/A

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2016 PRAXSYN CORPORATION (Exact name of Registrant as specified in its charter) Nevada 333-130446 20-3191557 (State or other jurisdiction of incorpor

April 6, 2016 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): March 31, 2016 PRAXSYN CORPORATION (Exact name of Registrant as specified in its charter) Nevada 333-130446 20-3191557 (State or other jurisdiction of incorporation) (Commission F

March 30, 2016 NT 10-K

Praxsyn 0-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form N-SAR For Period Ended: December 31, 2015 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] Transition Report on Form

March 29, 2016 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2016 PRAXSYN CORPORATION (Exact name of Registrant as specified in its charter) Nevada 333-130446 20-3191557 (State or other jurisdiction of incorporation) (Commission F

December 15, 2015 8-K/A

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No.1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): December 8, 2015 PRAXSYN CORPORATION (Exact name of Registrant as specified in its charter) Nevada 333-130446 20-3191557 (State or other jurisdiction of incorpo

December 14, 2015 EX-10.1

MARKETING SERVICES AGREEMENT

MARKETING SERVICES AGREEMENT This Marketing Services Agreement is entered into as of the 23rd day of January, 2015 by and between Mesa Pharmacy, Inc.

December 14, 2015 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): December 8, 2015 PRAXSYN CORPORATION (Exact name of Registrant as specified in its charter) Nevada 333-130446 20-3191557 (State or other jurisdiction of incorporation) (Commission

December 14, 2015 EX-10.2

AMENDMENT NO. 1 TO THE MARKETING SERVICES AGREEMENT

AMENDMENT NO. 1 TO THE MARKETING SERVICES AGREEMENT THIS AMENDMENT NO. 1 TO THE MARKETING SERVICES AGREEMENT (this ?Amendment No. 1?), is entered into as of February 3, 2015, by and between Products for Doctors, Inc., a California corporation (?Consultant?) and Mesa Pharmacy, Inc., a California corporation (?Client?) to amend Section 1.1 of the Marketing Services Agreement dated January 23, 2015 (

November 16, 2015 10-Q

Praxsyn (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal quarter ended September 30, 2015 or [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from .

July 27, 2015 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): July 21, 2015 PRAXSYN CORPORATION (Exact name of Registrant as specified in its charter) Nevada 333-130446 20-3191557 (State or other jurisdiction of incorporation) (Commission Fi

June 15, 2015 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): June 9, 2015 PRAXSYN CORPORATION (Exact name of Registrant as specified in its charter) Nevada 333-130446 20-3191557 (State or other jurisdiction of incorporation) (Commission Fil

June 15, 2015 EX-10.1

Services Agreement

Services Agreement This SERVICES AGREEMENT, is entered into as of June 9, 2015 (the ?Effective Date?), by and between NHS PHARMA SALES INC.

March 31, 2015 NT 10-K

Praxsyn 0-K

Form 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (CHECK ONE): [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form N-SAR For Period Ended: December 31, 2014 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] Transition R

February 26, 2015 EX-17.1

EX-17.1

EXHIBIT 17.1

February 26, 2015 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): January 28, 2015 PRAXSYN CORPORATION (Exact name of Registrant as specified in its charter) Nevada 333-130446 20-3191557 (State or other jurisdiction of incorporation) (C

February 4, 2015 8-K/A

Other Events

FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): December 31, 2014 PRAXSYN CORPORATION (Exact name of Registrant as specified in its charter) Nevada 333-130446 20-3191557 (State or other jurisdiction (

January 27, 2015 EX-10.2

NHS PHARMA SALES, Inc.

EXHIBIT 10.2 Marketing Company Agreement NHS PHARMA SALES, Inc. THIS AGREEMENT, entered into as of January 26, 2015 (the “Effective Date”) by and between NHS PHARMA SALES INC., a corporation organized and existing under the laws of the State of California (hereinafter referred to as “NHSPS” or the “Company”) whose legal address is 1323 W Colton Ave Suite 120, Redlands, CA 92374, and MESA PHARMACY

January 27, 2015 EX-10.1

SCRIPT PROCESSING SERVICE CONTRACT

EXHIBIT 10.1 NHS PHARMA, Inc. SCRIPT PROCESSING SERVICE CONTRACT 1. This contract is entered into and between NHS PHARMA, INC., a California corporation whose address is 1323 W Colton Ave., Suite 120, Redlands, CA 92374 referred to as “NHS, and Mesa Pharmacy, Inc., a California Corporation, herein after referred to as “NEW PHARMACY” whose address is: 2. NEW PHARMACY desires to process scripts to b

January 27, 2015 EX-3.1(I)

EX-3.1(I)

EXHIBIT 3.1(i)

January 27, 2015 EX-3.2(I)

ARTICLES OF INCORPORATION PRAXSYN CORPORATION

EXHIBIT 3.2(i) ROSS MILLER Secretary of State 204 North Carson Street, Suite 4 Carson City, Nevada 89701-4620 (776) 684-5708 Website: www.nvsos.gov Filed in the office of Ross Miller Secretary of State State of Nevada Document Number 20140834227-13 Articles of Domestication (PURSUANT TO NRS 92A.270) Filing Date and Time 12/30/2014 3:05 PM Entity Number E0648002014-2 USE BLACK INK ONLY - DO NOT HIG

January 27, 2015 8-K

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders

FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): January 21, 2015 PRAXSYN CORPORATION (Exact name of Registrant as specified in its charter) Nevada 333-130446 20-3191557 (State or other jurisdiction of incorporation) (C

November 14, 2014 NT 10-Q

PXYN / Praxsyn Corporation NT 10-Q - - NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (CHECK ONE): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR For Period Ended: September 30, 2014 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] Transition Report on Fo

November 4, 2014 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): November 3, 2014 PRAXSYN CORPORATION (Exact name of Registrant as specified in its charter) Illinois 333-130446 20-3191557 (State or other jurisdiction of incorporation) (Commissi

September 5, 2014 8-K

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): September 5, 2014 PRAXSYN CORPORATION (Exact name of Registrant as specified in its charter) Illinois 333-130446 20-3191557 (State or other jurisdiction of incorporation) (Commiss

August 13, 2014 NT 10-Q

PXYN / Praxsyn Corporation NT 10-Q - - NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (CHECK ONE): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR For Period Ended: June 30, 2014 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] Transition Report on Form N-

July 16, 2014 EX-99.1

Report of Independent Registered Public Accounting Firm

EX-99.1 2 ex99-1.htm EXHIBIT 99.1 Item 99.1 FINANCIAL STATEMENTS TABLE OF CONTENTS Page Report of Independent Registered Public Accounting Firm 2 Consolidated Balance Sheets as of December 31, 2013 and 2012 3 Consolidated Statements of Operations for the years ended December 31, 2013 and 2012 4 Consolidated Statements of Stockholders’ Deficit for the years ended December 31, 2013 and 2012 5 Consol

July 16, 2014 8-K/A

Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits

FORM 8-K/A United States Securities and Exchange Commission Washington, D.C. 20549 FORM 8-K/A Amendment No. 2 CURRENT REPORT Pursuant to Section 13 or 15[d] of the Securities Exchange Act of 1934 March 31, 2014 Date of Report PRAXSYN CORPORATION (Exact name of Registrant as specified in its Charter) Illinois 333-130446 20-3191557 (State or Other Jurisdiction of Incorporation) (Commission File Numb

July 16, 2014 EX-99.2

TABLE OF CONTENT

EXHIBIT 99.2 TABLE OF CONTENT Unaudited Pro Forma Condensed Combined Balance Sheet of Praxsyn and PDC as of December 31, 2013 3 Unaudited Pro Forma Condensed Combined Statement of Operations of Praxsyn and PDC for the year ended December 31, 2013 4 Notes to Unaudited Pro Forma Condensed Combined Financial Statements 5 1 The following unaudited pro forma condensed combined balance sheet reflects th

May 30, 2014 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - CURRENT REPORT

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2014 PRAXSYN CORPORATION (Exact name of Registrant as specified in its charter) Illinois 333-130446 20-3191557 (State or other jurisdiction of incorporation) (Comm

May 15, 2014 NT 10-Q

- NOTIFICATION OF LATE FILING

FORM 12B-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: March 31, 2014 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on

May 15, 2014 NT 10-Q/A

- AMENDMENT TO NT 10-Q

FORM 12B-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: March 31, 2014 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on

May 5, 2014 8-K

Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits - CURRENT REPORT

FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): May 5th, 2014 PRAXSYN CORPORATION (Exact name of Registrant as specified in its charter) Illinois 333-130446 20-3191557 (State or other jurisdiction (Commission (IRS Empl

May 5, 2014 EX-16.1

May 1, 2014

Exhibit 16.1 May 1, 2014 United States Securities and Exchange Commission Division of Corporate Finance 100 F Street, N.E. Washington, DC 20549 File Number: 333-130446 To Whom It May Concern: We have read and understand the statements that Praxsyn Corporation (the “Registrant” or the “Company”) will include under Item 4.01 of the Form 8-K report it will file regarding the change in independent reg

April 4, 2014 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 31, 2014 Date of Report (Date of earliest event reported) THE PAWS PET COMPANY, INC. (Exact name of registrant as specified in its charter) Illinois 333-130446 20-3191557 (State or other jurisdiction of incorporation) (Commissi

April 3, 2014 8-K/A

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Submission of Matters to a Vote of Security Holders, Completion of Acquisition or Disposition of Assets - AMENDMENT TO FORM 8-K

FORM 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 26, 2014 Date of Report (Date of earliest event reported) THE PAWS PET COMPANY, INC. (Exact name of registrant as specified in its charter) Illinois 333-130446 20-3191557 (State or other jurisdiction (Commission (I

April 1, 2014 8-K

Financial Statements and Exhibits, Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders - CURRENT REPORT

FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 26, 2014 Date of Report (Date of earliest event reported) THE PAWS PET COMPANY, INC. (Exact name of registrant as specified in its charter) Illinois 333-130446 20-3191557 (State or other jurisdiction (Commission (IRS E

March 31, 2014 NT 10-K

- NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: 12/31/2013 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] Tr

March 26, 2014 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits - CURRENT REPORT

FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 20, 2014 Date of Report (Date of earliest event reported) THE PAWS PET COMPANY, INC. (Exact name of registrant as specified in its charter) Illinois 333-130446 20-3191557 (State or other jurisdiction of (Commission Fil

March 26, 2014 EX-10

AGREEMENT AND PLAN OF MERGER

EXHIBIT 10 AGREEMENT AND PLAN OF MERGER AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of March 20, 2014, by and among The PAWS Pet Company, Inc.

January 7, 2014 EX-10.1

FIRST AMENDED SECURITIES EXCHANGE AGREEMENT

EXHIBIT 10.1 FIRST AMENDED SECURITIES EXCHANGE AGREEMENT This FIRST AMENDED SECURITIES EXCHANGE AGREEMENT (the “Agreement”), is made effective as of this 31st day of December 2013, by and among THE PAWS PET COMPANY, INC., an Illinois corporation (“PAWS”), having its principal place of business at 855 El Camino Real, Suite 13A-184, Palo Alto, California 94301 and PHARMACY DEVELOPMENT CORP., a Calif

January 7, 2014 8-K

Financial Statements and Exhibits, Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 7, 2014 Date of Report (Date of earliest event reported) THE PAWS PET COMPANY, INC. (Exact name of registrant as specified in its charter) Illinois 333-130446 20-3191557 (State or other jurisdiction of (Commission File (IRS E

January 7, 2014 EX-10.4

REQUIRED SHAREHOLDER ACTIONS PURSUANT TO SECTION 1.4(b)

EXHIBIT 10.4 EXHIBIT C REQUIRED SHAREHOLDER ACTIONS PURSUANT TO SECTION 1.4(b) 1. To change the name of the Company to, “Praxsyn Corporation.” 2. To increase the number of authorized shares of Common Stock to number of shares sufficient to provide for the conversion, if demanded, of all authorized shares of preferred stock, all outstanding warrants, options and convertible debenture, if any. 3. To

January 7, 2014 EX-10.3

ROYALTY AGREEMENT

EXHIBIT 10.3 EXHIBIT B ROYALTY AGREEMENT This ROYALTY AGREEMENT (this “Royalty Agreement”), is made effective as of this 30th day of December 2013 (the “Effective Date”), by and among MESA PHARMACY, INC., a California corporation (“MESA”) and PHARMACY DEVELOPMENT CORP., a California corporation (“PDC”), both having as their principal place of business, 18013 Sky Park Circle, Suite D, Irvine, CA 92

January 7, 2014 EX-10.2

TERMS OF PREFERRED STOCK

EXHIBIT 10.2 EXHIBIT A The undersigned Daniel Wiesel, hereby certifies that: 1. He is the Chairman of the Board of Directors and the Chief Executive Officer of The PAWS Pet Company, Inc., an Illinois corporation (the “Corporation”). 2. The Corporation is authorized to issue 10,000,000 shares of preferred stock, none of which are issued or outstanding. 3. That on December 27, 2013 the following res

October 31, 2013 EX-10.1

SECURITIES EXCHANGE AGREEMENT

EXHIBIT 10.1 Exhibit 10.1 SECURITIES EXCHANGE AGREEMENT This SECURITIES EXCHANGE AGREEMENT (the “Agreement”), is made effective as of this 28th day of October 2013, by and among THE PAWS PET COMPANY, INC., an Illinois corporation (“PAWS”), having its principal place of business at 855 El Camino Real, Suite 13A-184, Palo Alto, California 94301 and PHARMACY DEVELOPMENT CORP., a California corporatio

October 31, 2013 EX-10.3

ROYALTY AGREEMENT

Exhibit 10.3 Exhibit 10.3 EXHIBIT C ROYALTY AGREEMENT This ROYALTY AGREEMENT (this “Royalty Agreement”), is made effective as of this 28th day of October 2013 (the “Effective Date”), by and among MESA PHARMACY, INC., a California corporation (“MESA”) and PHARMACY DEVELOPMENT CORP., a California corporation (“PDC”), both having as their principal place of business, 18013 Sky Park Circle, Suite D, I

October 31, 2013 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits - CURRENT REPORT

FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 29, 2013 Date of Report (Date of earliest event reported) THE PAWS PET COMPANY, INC. (Exact name of registrant as specified in its charter) Illinois 333-130446 20-3191557 (State or other jurisdiction (Commission (IRS

October 31, 2013 EX-10.2

TERMS OF PREFERRED STOCK

EXHIBIT 10.2 Exhibit 10.2 EXHIBIT A The undersigned Daniel Wiesel, hereby certifies that: 1. He is the Chairman of the Board of Directors and the Chief Executive Officer of The PAWS Pet Company, Inc., an Illinois corporation (the “Corporation”). 2. The Corporation is authorized to issue 10,000,000 shares of preferred stock, none of which are issued or outstanding. 3. That on October 29, 2013 the f

September 12, 2013 8-K

Other Events, Financial Statements and Exhibits - CURRENT REPORT

FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 10, 2013 Date of Report (Date of earliest event reported) THE PAWS PET COMPANY, INC. (Exact name of registrant as specified in its charter) Illinois 333-130446 20-3191557 (State or other jurisdiction of (Commissio

September 12, 2013 EX-99.1

The PAWS Pet Company, Inc. to Acquire MESA Pharmacy of Irvine, CA

EXHIBIT 99-1 Exhibit 99.1 The PAWS Pet Company, Inc. to Acquire MESA Pharmacy of Irvine, CA Palo Alto, CA – Sept 10, 2013 - The PAWS Pet Company, Inc. (OTCQB:PAWS) (OTCPK:PAWS), announced it has signed a letter of intent to acquire Pharmacy Development, Inc., dba MESA Pharmacy, of Irvine, California as part on its new strategy to be a dominant player in the delivery of pharmaceutical products to c

June 7, 2013 EX-10.4

SECURITIES EXCHANGE AGREEMENT

Exhibit 10.4 Exhibit 10.4 SECURITIES EXCHANGE AGREEMENT THIS SECURITIES EXCHANGE AGREEMENT (“Agreement”) is made effective this 7th day of May, 2013 between Fantasy Funding, Inc., a Colorado corporation (“FFI”), Destiny Diversification Holdings Corp., a Colorado corporation (“DDHC”) and The PAWS Pet Company, Inc., an Illinois corporation (the “Corporation” or “PAWS”), on the other hand. RECITALS W

June 7, 2013 EX-10.1

SECURITIES EXCHANGE AGREEMENT

Exhibit 10.1 Exhibit 10.1 SECURITIES EXCHANGE AGREEMENT THIS SECURITIES EXCHANGE AGREEMENT (“Agreement”) is made effective this 7th day of May, 2013 between Bellevue Holdings, Inc., an Illinois corporation (“BHI”) and The PAWS Pet Company, Inc., an Illinois corporation (the “Corporation” or “PAWS”), on the other hand. RECITALS WHEREAS, the Corporation is a publicly traded company that currently tr

June 7, 2013 EX-10.5

AGREEMENT OF SETTLEMENT AND GENERAL RELEASE

Exhibit 10.5 Exhibit 10.5 AGREEMENT OF SETTLEMENT AND GENERAL RELEASE THIS AGREEMENT OF SETTLEMENT AND GENERAL RELEASE (“Agreement”) is made effective this 7th day of May, 2013 between Fantasy Funding, Inc., an Colorado corporation, its affiliates and their respective officers, directors and shareholders, agents, employees and assigns and all parties acting by, through, under or in concert with an

June 7, 2013 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Unregistered Sales of Equity Securities, Financial Statements and Exhibits - CURRENT REPORT

FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 10, 2013 Date of Report (Date of earliest event reported) THE PAWS PET COMPANY, INC. (Exact name of registrant as specified in its charter) Illinois 333-130446 20-3191557 (State or other jurisdiction (Commission (IRS Emp

June 7, 2013 EX-10.3

SECURITIES EXCHANGE AGREEMENT

Exhibit 10.3 Exhibit 10.3 SECURITIES EXCHANGE AGREEMENT THIS SECURITIES EXCHANGE AGREEMENT (“Agreement”) is made effective this 7th day of May, 2013 between Fantasy Funding, Inc., an Colorado corporation (“FFI”) and The PAWS Pet Company, Inc., an Illinois corporation (the “Corporation” or “PAWS”), on the other hand. RECITALS WHEREAS, the Corporation is a publicly traded company that currently trad

June 7, 2013 EX-10.2

AGREEMENT OF SETTLEMENT AND GENERAL RELEASE

Exhibit 10.2 Exhibit 10.2 AGREEMENT OF SETTLEMENT AND GENERAL RELEASE THIS AGREEMENT OF SETTLEMENT AND GENERAL RELEASE (“Agreement”) is made effective this 7th day of May, 2013 between Bellevue Holdings, Inc., an Illinois corporation, its affiliates and their respective officers, directors and shareholders, agents, employees and assigns and all parties acting by, through, under or in concert with

April 1, 2013 NT 10-K

-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: 12/31/2012 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] Tr

March 15, 2013 EX-10.2

EXHIBIT B

Exhibit 10.2 Exhibit 10.2 EXHIBIT B The undersigned Daniel Wiesel, hereby certifies that: 1. He is the Chairman of the Board of Directors and the Chief Executive Officer of The PAWS Pet Company, Inc., an Illinois corporation (the “Corporation”). 2. The Corporation is authorized to issue 10,000,000 shares of preferred stock, none of which are issued or outstanding. 3. That on March 9th 2013, the fo

March 15, 2013 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets -

FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 9, 2013 Date of Report (Date of earliest event reported) THE PAWS PET COMPANY, INC. (Exact name of registrant as specified in its charter) Illinois 333-130446 20-3191557 (State or other jurisdiction (Commission (IRS Em

March 15, 2013 EX-10.1

SECURITIES EXCHANGE AGREEMENT

Exhibit 10.1 Exhibit 10.1 SECURITIES EXCHANGE AGREEMENT THIS SECURITIES EXCHANGE AGREEMENT (the “Agreement”), is made effective as of this 9th day of March 2013, by and among THE PAWS PET COMPANY, INC., an Illinois corporation (“PAWS”), having its principal place of business at 455 NE 5th Avenue, #D264, Delray Beach, 33483, ADVANCED ACCESS PHARMACY SERVICES, LLC, a Nevada limited liability company

February 8, 2013 15-15D/A

-

Form 15-12G/A UNITED STATES OMB APPROVAL OMB Number: 3235-0167 Expires: December 31, 2014 Estimated average burden hours per response .

February 6, 2013 RW

- REQUEST FOR WITHDRAWAL

PAWS PET COMPANY, INC., 455 N.E. 5th Avenue, Suite D464, Delray Beach, FL 33483 (561) 274-6805 Via Edgar February 06, 2013 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street N.E. Washington D.C. 20002 Re: Paws Pet Company, Inc., Request to Withdraw Form 15 filed November 13, 2012 File No: 333-130446 Ladies and Gentlemen: Paws Pet Company, Inc., (the “Regi

November 13, 2012 15-15D

-

Form 15 UNITED STATES OMB APPROVAL OMB Number: 3235-0167 Expires: December 31, 2014 Estimated average burden hours per response .

September 18, 2012 8-K

-

Form 8K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) September 17, 2012 THE PAWS PET COMPANY, INC. (Exact name of registrant as specified in its charter) ILLINOIS 333-130446 20-3191557 (State or other jurisdiction of incorporatio

July 26, 2012 EX-4.1

SECURITIES PURCHASE AGREEMENT

Exhibit 4.1 EXHIBIT 4.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of July 17, 2012, by and between THE PAWS PET COMPANY, INC., an Illinois corporation, with headquarters located at 777 East Atlantic Avenue - C-254, Delray Beach, FL 33483 (the “Company”), and ASHER ENTERPRISES, INC., a Delaware corporation, with its address at 1 Linden Place, Suite

July 26, 2012 EX-10.1

CONVERTIBLE PROMISSORY NOTE

EXHIBIT 10.1 EXHIBIT 10.1 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION S

July 26, 2012 8-K

- CURRENT REPORT

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) July 26, 2012 THE PAWS PET COMPANY, INC. (Exact name of registrant as specified in its charter) ILLINOIS 333-130446 20-3191557 (State or other jurisdiction of incorporation) (

July 20, 2012 8-K

- CURRENT REPORT

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) July 20, 2012 THE PAWS PET COMPANY, INC. (Exact name of registrant as specified in its charter) ILLINOIS 333-130446 20-3191557 (State or other jurisdiction of incorporation) (

July 20, 2012 EX-3.1

EX-3.1

Exhibit 3.1

July 9, 2012 EX-4.1

THE PAWS PET COMPANY, INC. Common stock SUBSCRIPTION AGREEMENT

Exhibit 4.1 THE PAWS PET COMPANY, INC. Common stock SUBSCRIPTION AGREEMENT Background The PAWS Pet Company and entered into an Agreement dated June , 2012, whereby in exchange for an Investment in The PAWS Pet Company agreed to issue restricted common shares to the Investor in exchange for an investment of $ or $0.01 per share. 1.1 Subscription. The undersigned (the “Subscriber”), intending to be

July 9, 2012 8-K

- CURRENT REPORT

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) June 19, 2012 THE PAWS PET COMPANY, INC. (Exact name of registrant as specified in its charter) ILLINOIS 333-130446 20-3191557 (State or other jurisdiction of incorporation) (

June 19, 2012 EX-4.1

THE PAWS PET COMPANY, INC. Common stock SUBSCRIPTION AGREEMENT

Exhibit 4.1 Exhibit 4.1 THE PAWS PET COMPANY, INC. Common stock SUBSCRIPTION AGREEMENT Background The PAWS Pet Company and entered into an Agreement dated June , 2012, whereby in exchange for an Investment in The PAWS Pet Company agreed to issue restricted common shares to the Investor in exchange for an investment of $ or $0.01 per share. 1.1 Subscription. The undersigned (the “Subscriber”), inte

June 19, 2012 8-K

- CURRENT REPORT

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) June 19, 2012 THE PAWS PET COMPANY, INC. (Exact name of registrant as specified in its charter) ILLINOIS 333-130446 20-3191557 (State or other jurisdiction of incorporation) (

May 11, 2012 S-8 POS

- AMENDMENT 3 TO FORM S-8

Form S-8 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 3 TO FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 THE PAWS PET COMPANY, INC. (Exact name of registrant as specified in its charter) Illinois 20-3191557 (State of other jurisdiction of incorporation or organization (I.R.S. Employer Identification No.) 777 E. Atlantic Ave, Suite C2 264

May 8, 2012 S-8 POS

- AMENDMENT TO S-8

Form S-8 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 THE PAWS PET COMPANY, INC. (Exact name of registrant as specified in its charter) Illinois 20-3191557 (State of other jurisdiction of incorporation or organization (I.R.S. Employer Identification No.) 777 E. Atlantic Ave, Suite C2 264

April 27, 2012 8-K

- CURRENT REPORT

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) April 27, 2012 THE PAWS PET COMPANY, INC. (Exact name of registrant as specified in its charter) ILLINOIS 333-130446 20-3191557 (State or other jurisdiction of incorporation)

April 27, 2012 EX-4.1

THE PAWS PET COMPANY, INC. 2012STOCK INCENTIVE PLAN

Exhibit 4.1 THE PAWS PET COMPANY, INC. 2012STOCK INCENTIVE PLAN This THE PAWS PET COMPANY, Inc. 2012 Stock Incentive Plan (the “Plan”) is designed to retain directors, executives and selected employees and consultants and reward them for making contributions to the success of the Company. These objectives are accomplished by making long-term incentive awards under the Plan thereby providing Partic

April 27, 2012 S-8 POS

- AMENDMENT TO S-8

Form S-8 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 THE PAWS PET COMPANY, INC. (Exact name of registrant as specified in its charter) Illinois 20-3191557 (State of other jurisdiction of incorporation or organization (I.R.S. Employer Identification No.) 777 E. Atlantic Ave, Suite C2 264

April 26, 2012 EX-10

CONVERTIBLE PROMISSORY NOTE

Exhibit 10.1 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR

April 26, 2012 S-8

- EMPLOYEE STOCK

Form S-8 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 THE PAWS PET COMPANY, INC. (Exact name of registrant as specified in its charter) Illinois 20-3191557 (State of other jurisdiction of incorporation or organization (I.R.S. Employer Identification No.) 777 E. Atlantic Ave, Suite C2 264 Delray Beach, FL 33

April 26, 2012 EX-4

SECURITIES PURCHASE AGREEMENT

Exhibit 4.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of April 16, 2012, by and betweenTHE PAWS PET COMPANY, INC., anIllinois corporation, with headquarters located at 777 East Atlantic Avenue - C-254, Delary Beach, FL 33483(the “Company”), and ASHER ENTERPRISES, INC., a Delaware corporation, with its address at 1 Linden Place, Suite 207, Great Ne

April 26, 2012 EX-4.1

THE PAWS PET COMPANY, INC. 2012STOCK INCENTIVE PLAN

Exhibit 4.1 THE PAWS PET COMPANY, INC. 2012STOCK INCENTIVE PLAN This THE PAWS PET COMPANY, Inc. 2012 Stock Incentive Plan (the “Plan”) is designed to retain directors, executives and selected employees and consultants and reward them for making contributions to the success of the Company. These objectives are accomplished by making long-term incentive awards under the Plan thereby providing Partic

April 26, 2012 8-K

- CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) April 26, 2012 THE PAWS PET COMPANY, INC. (Exact name of registrant as specified in its charter) ILLINOIS 333-130446 20-3191557 (State or other jurisdiction of incorporation) (Commissi

March 7, 2012 EX-10.1

CONVERTIBLE PROMISSORY NOTE

Exhibit 10.1 Exhibit 10.1 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION S

March 7, 2012 EX-4.1

SECURITIES PURCHASE AGREEMENT

Exhibit 4.1 Exhibit 4.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of February 27, 2012, by and betweenTHE PAWS PET COMPANY, INC., an Illinois corporation, with headquarters located at 2001 Gateway Place - Suite 410, San Jose, CA 95110(the “Company”), and ASHER ENTERPRISES, INC., a Delaware corporation, with its address at 1 Linden Place, Suite 207

March 7, 2012 8-K

- CURRENT REPORT

FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) March 7, 2012 THE PAWS PET COMPANY, INC. (Exact name of registrant as specified in its charter) ILLINOIS 333-130446 20-3191557 (State or other jurisdiction of incorporation) (

February 29, 2012 EX-2.1

Share Exchange Agreement

Exhibit 2.1 Share Exchange Agreement THIS AGREEMENT (the “Agreement” and/or the “Share Exchange”) is entered into between PAWS Pet Corporation an Illinois corporation having its registered office at 777 E. Atlantic Avenue C2-264, Delray Beach, Florida 33483, PAWS and the Shareholders of Impact Social Networking Inc., accompany incorporated in Georgia with an official address of 1373 Louis Ave, Elk

February 29, 2012 8-K

Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) February 29, 2012 THE PAWS PET COMPANY, INC. (Exact name of registrant as specified in its charter) ILLINOIS 333-130446 20-3191557 (State or other jurisdiction of incorporation) (Commi

January 10, 2012 CORRESP

-

THE PAWS PET COMPANY, INC. 2001 Gateway Place, Suite 410 San Jose, CA 95110 January 10, 2012 EDGAR Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Loan Lauren P. Nguyen Sonya Bednarowski Re: The PAWS Pet Company, Inc. Amendment No. 7 to Registration Statement on Form S-1 Filed January 10, 2012 File No. 333-175026 Ladies and Ge

January 10, 2012 S-1/A

-

As filed with the Securities and Exchange Commission on January 10, 2012 Registration No.

January 10, 2012 CORRESP

-

SICHENZIA ROSS FRIEDMAN FERENCE LLP 61 Broadway, 32nd Floor New York, NY 10006 January 10, 2012 Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, D.

December 19, 2011 CORRESP

-

SICHENZIA ROSS FRIEDMAN FERENCE LLP 61 Broadway, 32nd Floor New York, NY 10006 December 19, 2011 Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, D.

December 19, 2011 S-1/A

- S-1/A

As filed with the Securities and Exchange Commission on December 19, 2011 Registration No.

December 5, 2011 CORRESP

-

December 5, 2011 Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, D.

December 5, 2011 S-1/A

- FORM S-1/A

As filed with the Securities and Exchange Commission on December 5, 2011 Registration No.

November 2, 2011 CORRESP

-

November 2, 2011 Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, D.

October 13, 2011 CORRESP

-

October 13, 2011 Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, D.

September 9, 2011 CORRESP

-

September 9, 2011 Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, D.

August 9, 2011 CORRESP

-

August 8, 2011 Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, D.

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista